Literature DB >> 15568600

Fatal myocarditis: morphologic and clinical features.

Elisa Carniel1, Gianfranco Sinagra, Rossana Bussani, Andrea Di Lenarda, Bruno Pinamonti, Gerardina Lardieri, Furio Silvestri.   

Abstract

BACKGROUND: Autopsy studies report a frequency of myocarditis ranging from 0.11 to 5.5% in the general population, reaching almost 50% in selected groups. Myocarditis is often undiagnosed and the incidence of fatal course myocarditis has never been evaluated. The aim of our study was to assess the frequency of fatal course myocarditis in a consecutive series of autopsies and to describe the clinical, histological and morphologic features of the disease.
METHODS: From January 1, 1995 to January 31, 1996, 2560 autopsies were performed, and 143 cases of active myocarditis were diagnosed (5.6%).
RESULTS: In 39 cases (1.5%; 12 males; 4/39 aged < or = 35 years) active myocarditis was identified as the final cause of death. Only in 1 case was myocarditis suspected ante-mortem. The histological pattern was lymphocytic in 64% of cases. A mixed inflammatory infiltration was found in 33% and a granulomatous infiltration in 3%. In 49% of cases myocarditis was localized in both ventricles and the interventricular septum. The clinical presentation of myocarditis was heart failure in 18/39 patients (46%), cardiac arrest in 4/39 patients (10%) and syncope and chest pain in 1/39 patient (3%). The mean creatine phosphokinase levels were 890 +/- 2742 IU/I (assessed in 11/39 patients, 28%) but they were increased only in 7/39 (18%). ECG (performed in 29/39 patients, 74%) showed sinus rhythm in 16/39 patients (55%, > 100 b/min in 41%), atrioventricular or interventricular conduction defects in 10/39 patients (34%) and a pathological Q wave in 4/39 patients (14%). At echocardiography (performed in 7/39 patients, 18%), right and/or left ventricular dysfunction was found to be present in 5 cases (71%) and a pericardial effusion in 4 cases (57%).
CONCLUSIONS: Myocarditis is underdiagnosed ante-mortem. A high index of clinical suspicion is mandatory for prompt diagnosis and treatment of this fatal disease seen also in the young.

Entities:  

Mesh:

Year:  2004        PMID: 15568600

Source DB:  PubMed          Journal:  Ital Heart J        ISSN: 1129-471X


  12 in total

1.  Immunological and pathological consequences of coxsackievirus RNA persistence in the heart.

Authors:  Claudia T Flynn; Taishi Kimura; Kwesi Frimpong-Boateng; Stephanie Harkins; J Lindsay Whitton
Journal:  Virology       Date:  2017-12       Impact factor: 3.616

2.  Assessment of edema using STIR+ via 3D cardiovascular magnetic resonance imaging in patients with suspected myocarditis.

Authors:  Michael Jeserich; Bela Merkely; Pascal Schlosser; Simone Kimmel; Gabor Pavlik; Stephan Achenbach
Journal:  MAGMA       Date:  2017-01-16       Impact factor: 2.310

3.  Natural killer cells limit cardiac inflammation and fibrosis by halting eosinophil infiltration.

Authors:  SuFey Ong; Davinna L Ligons; Jobert G Barin; Lei Wu; Monica V Talor; Nicola Diny; Jillian A Fontes; Elizabeth Gebremariam; David A Kass; Noel R Rose; Daniela Čiháková
Journal:  Am J Pathol       Date:  2015-01-23       Impact factor: 4.307

4.  In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.

Authors:  Nadine Althof; Stephanie Harkins; Christopher C Kemball; Claudia T Flynn; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  J Virol       Date:  2014-02-26       Impact factor: 5.103

5.  Cardiovascular magnetic resonance in myocarditis: A JACC White Paper.

Authors:  Matthias G Friedrich; Udo Sechtem; Jeanette Schulz-Menger; Godtfred Holmvang; Pauline Alakija; Leslie T Cooper; James A White; Hassan Abdel-Aty; Matthias Gutberlet; Sanjay Prasad; Anthony Aletras; Jean-Pierre Laissy; Ian Paterson; Neil G Filipchuk; Andreas Kumar; Matthias Pauschinger; Peter Liu
Journal:  J Am Coll Cardiol       Date:  2009-04-28       Impact factor: 24.094

6.  Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation.

Authors:  Daniela Cihakova; Jobert G Barin; Marina Afanasyeva; Miho Kimura; DeLisa Fairweather; Michael Berg; Monica V Talor; G Christian Baldeviano; Sylvia Frisancho; Kathleen Gabrielson; Djahida Bedja; Noel R Rose
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

7.  Diagnosis of viral myocarditis by cardiac magnetic resonance and viral genome detection in peripheral blood.

Authors:  Michael Jeserich; Eva Brunner; Reinhard Kandolf; Manfred Olschewski; Simone Kimmel; Matthias G Friedrich; Daniela Föll; Christoph Bode; Annette Geibel
Journal:  Int J Cardiovasc Imaging       Date:  2012-05-06       Impact factor: 2.357

Review 8.  Myocarditis.

Authors:  Lori A Blauwet; Leslie T Cooper
Journal:  Prog Cardiovasc Dis       Date:  2010 Jan-Feb       Impact factor: 8.194

9.  Diagnosis of early myocarditis after respiratory or gastrointestinal tract viral infection: insights from cardiovascular magnetic resonance.

Authors:  Michael Jeserich; Stavros Konstantinides; Manfred Olschewski; Gabor Pavlik; Christoph Bode; Annette Geibel
Journal:  Clin Res Cardiol       Date:  2010-05-28       Impact factor: 5.460

Review 10.  Non-invasive imaging in the diagnosis of acute viral myocarditis.

Authors:  Michael Jeserich; Stavros Konstantinides; Gabor Pavlik; Christoph Bode; Annette Geibel
Journal:  Clin Res Cardiol       Date:  2009-09-11       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.